{
    "nct_id": "NCT03750513",
    "official_title": "Pilot Trial of LET Optimized IMPT for Pediatric Patients With Ependymoma",
    "inclusion_criteria": "* Previous pathologic confirmation of ependymoma, World Health Organization (WHO) grade II or III\n* Disease must be confined to the brain (no evidence of spread on MR imaging of the spine or on staging lumbar puncture)\n* Patient may not receive chemotherapy concurrent with radiation\n* Signed informed consent by patient and/or parents or legal guardian\n* Lansky performance status score of 50 -100\nHealthy volunteers allowed\nMust have maximum age of 22 Years",
    "exclusion_criteria": "* Patients with previous radiation therapy to the brain\n* Ependymoma of the spine\n* Disseminated ependymoma requiring craniospinal radiation therapy\n* Pregnancy\n* Inability to undergo MR imaging\n* Inability to receive gadolinium-based contrast agent",
    "miscellaneous_criteria": ""
}